ACMR three-lens brief
Evidence-based stock research on ACMR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price up 7.73% in the last session — a material single-day move. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Price up 7.73% in the last session — a material single-day move.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 34.8pp over 30 days.
- Analyst mean target $103.56 — 98% above current (9 analysts).
- Negative free cash flow last quarterly (-$284.23M).
ACMR closed at $52.43 (+7.73%) as of 2026-11-12. Market cap: $3.67B. P/E (trailing) 32.8. Price is below the 50-day MA and below the 200-day MA. Positives: price up 7.73% in the last session — a material single-day move.; analyst mean target $103.56 — 98% above current (9 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; underperforming SPY by 34.8pp over 30 days.. Last quarter: Revenue $367.69M, net income $1.54M, free cash flow -$284.23M.
Why three lenses on ACMR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ACMR across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ACMR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ACMR brief"></iframe>